NEW YORK, May 21 /PRNewswire-FirstCall/ -- China Aoxing Pharmaceutical Company, Inc. , a pharmaceutical company based in China that specializes in analgesics and pain management products, including Oxycodone, Pholcodine, Naloxone, and Tilidine, today announced that the Company will attend the Red Chip Small-Cap Investor Conference on May 29, 2007 at the Ritz Carlton Hotel in San Francisco, California.
Management is currently scheduled to present at 1:45 pm PT / 4:45 pm ET. Listeners may access a live webcast of the presentation by visiting http://www.redchip.com. Investors who would like more information about attending the Red Chip Small-Cap Conference should contact Red Chip directly or visit their website at www.redchip.com.
About China Aoxing Pharmaceutical Group
China Aoxing Pharmaceutical Company, Inc. is a pharmaceutical company in China specializes in research, development, manufacturing and distribution of a variety of analgesics and pain management products. Its operating subsidiary, Hebei Aoxing Pharmaceutical Group Co. Ltd, is a corporation organized under the laws of the People’s Republic of China. Hebei Aoxing is one of only a handful of companies in China to be granted the license to manufacture drugs, including Oxycodone, Pholcodine, Naloxone, Tilidine, and is working closely with the Chinese government to assure their availability throughout China.
Contact: Ashley M. Ammon & Bill Zima Integrated Corporate Relations, Inc. 203 682 8200
China Aoxing Pharmaceutical Company, Inc.
CONTACT: Ashley M. Ammon & Bill Zima, both of Integrated CorporateRelations, Inc., +1-203-682-8200, for China Aoxing Pharmaceutical Company,Inc.
Web site: http://www.redchip.com/
